Intravitreal injection of Avastin or Lucentis causes very rapid regression of the neovascularization of the iris and angle, thereby preventing angle closure and further progression. This suggests that if (Read more...)
AAO 2008: Anti-VEGF Therapy in Glaucoma with Farnaz Memarzadeh, MD
Farnaz Memarzadeh, MD, describes anti-VEGF therapy in glaucoma in an interview with Dr. Brian Francis at the 2008 AAO meeting in Atlanta. Dr. Memarzadeh reviews some of the indications where anti-VEGF therapy may be used: neovascular glaucoma (NVG), as an adjunct to trabeculectomy in place of MMC or 5-FU, or as a rescue therapy in the event of a failed trabeculectomy.